scholarly article | Q13442814 |
P2093 | author name string | Hong-Wei Wang | |
Ya Zhuo | |||
Li-Juan Hou | |||
Xiao-Xia Wei | |||
Xin-Wen Song | |||
Bao-Sheng Shen | |||
Shu-Peng Duan | |||
P2860 | cites work | Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 |
Fatigue and psychological disorders in chronic hepatitis C. | Q43967439 | ||
Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression | Q44239124 | ||
Clinical diagnosis of depression in primary care: a meta-analysis | Q44323103 | ||
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a | Q44403521 | ||
Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
Brain and mind: a challenge for WHO. | Q48284196 | ||
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. | Q51961246 | ||
Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. | Q52922033 | ||
Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
Health-Related Quality of Life and Depression in Patients with Chronic Hepatitis C | Q63305767 | ||
Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study | Q68123737 | ||
Hepatitis B vaccines | Q84685515 | ||
The human urine metabolome | Q21132532 | ||
Metabolomics and cardiovascular biomarker discovery | Q26991473 | ||
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections | Q30977897 | ||
Analysis of metabolomic data using support vector machines | Q33366103 | ||
Depression in patients with chronic hepatitis B: an experience on individual solution- focused therapy | Q33596472 | ||
Metabolomics: a global biochemical approach to drug response and disease | Q34734298 | ||
Potential metabolite markers of schizophrenia. | Q36479055 | ||
Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin) | Q37612891 | ||
Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. | Q37733240 | ||
SOME STEP-DOWN PROCEDURES CONTROLLING THE FALSE DISCOVERY RATE UNDER DEPENDENCE. | Q42115270 | ||
Cognitive performance and mood in patients on the waiting list for liver transplantation and their relation to the model for end-stage liver disease | Q43118011 | ||
P433 | issue | 4 | |
P921 | main subject | Hepatitis B virus | Q6844 |
P304 | page(s) | e27359 | |
P577 | publication date | 2015-04-25 | |
P1433 | published in | Iranian Red Crescent medical journal | Q26842886 |
P1476 | title | Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients | |
P478 | volume | 17 |
Q57161916 | GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age |
Q94560996 | Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior |
Q37474509 | Noninvasive metabolic profiling for painless diagnosis of human diseases and disorders |
Q36693671 | Psychological Reactions among Patients with Chronic Hepatitis B: a Qualitative Study |
Q57155162 | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders |
Search more.